Research Area B
In Research Area B, based on the previously identified key drivers of transition, we will use both pharmacological and non-pharmacological approaches to prevent the progression towards clinical manifestations of autoimmune disease.
Details for each project are provided on the left.
- Projects
- 1st Generation
- 2nd Generation
- A: Defining Autoimmune Pre-Disease
- B: Targeting of Autoimmune Pre-Disease
- B4: Nutritional treatments to improve inflammatory IgG Fc glycosylation
- B5: Reversal of autoimmune pre-disease by weight loss
- B6: Modulation of T cell receptor repertoire in autoimmunity after treatment with cell-derived nanoparticles
- B7: Targeting IL-13 signaling pathway as a potential therapeutic approach in experimental models of pulmonary arterial hypertension.
- Associated projects
- Medical doctoral researcher projects
- Concluded projects
